ClinicalTrials.Veeva

Menu

Prognostic Value of CTC in HNSCC Patients (CTCHNSCC01)

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Terminated

Conditions

Death
Metastasis
Recurrence

Study type

Observational

Funder types

Other

Identifiers

NCT01884129
CTCHNSCC01
CMRPG3B0971~3 (Other Grant/Funding Number)

Details and patient eligibility

About

We hypothesized that the number of circulating tumor cells (CTCs) and molecular markers on CTCs could be a prognostic factor or predictive factor to patients with head neck cancer.

Full description

  1. Histologically or cytopathologically proven head and neck squamous cell carcinoma (HNSCC)

  2. Disease status: locally advanced or recurrent/metastasized at initial presentation

  3. Age >=20 years old

  4. Could understand and signed the informed consents of this study

  5. Enrolled patients were classified into three distinct subgroups:

    1. Patients underwent curative surgery followed by adjuvant chemoradiotherapy (CRT) because of some pathologic features such as positive margin, pathologic N2, and extracapsular spread (ECS) of involved lymph nodes indicating early relapse according to recommendation from National Comprehensive Cancer Network(NCCN) guidelines;
    2. Patients with advanced disease directly underwent definitive concurrent chemoradiotherapy(CCRT);
    3. Patients were to have palliative chemotherapy for existence of distant metastasis or poor general condition for definitive CCRT.
  6. Blood samples were collected within 7 days before the first dose of chemotherapy.

Enrollment

53 patients

Sex

All

Ages

20+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • histologically or cytopathologically proven head and neck squamous cell carcinoma Age ≥ 20 years. Measurable or evaluable disease according to Response Evaluation Criteria In Solid Tumors(RECIST) criteria.

Ability to sign informed consent.

Exclusion criteria

  • Prior cancers within 5 years, except for non-melanoma skin cancers, and in situ cervical cancers.

Inability to comply with study and/or follow-up procedures.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems